Dr. Emmanuel Antonarakis provides an update on treating chemo-naive metastatic hormone sensitive prostate cancer and then discusses the impact of AR-V7 in Castration Resistant Prostate Cancer.

Keywords: AR-V7, Castration Resistant Prostate Cancer